Molecular Medicine Partnership Unit Medical Campus of the University of Heidelberg, Germany. Research themes place emphasis on common diseases, particularly blood disorders, cancer, iron metabolism disorders, chronic pain, diseases associated with aging, and AIDS. In 2018 more than 110 scientists from across the world work on these eight research themes: Molecular Medicine Partnership Unit The Molecular Medicine Partnership Unit (MMPU) is an alliance between the European Molecular Biology Laboratory (EMBL) and the Medical Faculty of the University of Heidelberg. Its primary aim is to uncover the molecular basis of disease and to speed the transformation of biomedical discoveries into personalized medicine strategies. Founded in
Disorders of sex development medical "disorders") has been controversial. The argument over terminology reflects a deeper disagreement over the extent to which intersex conditions require medical intervention, the appropriateness of certain interventions, and whether physicians and parents should make irreversible treatment decisions on behalf of young children if the condition is not life-threatening. The 2006 "Consensus statement on management of intersex disorders" stated that evidence for early surgery for cosmetic reasons is lacking, outcomes include "decreased sexual sensitivity" and long term outcome data is absent. A 2016 "Global Disorders of Sex Development Update since 2006" states that there is "still no consensual attitude regarding